+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Altretamine Market by Distribution Channel, End User, Product Type - Global Forecast to 2030- Product Image
Altretamine Market by Distribution Channel, End User, Product Type - Global Forecast to 2030- Product Image
Sale

Altretamine Market by Distribution Channel, End User, Product Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015156
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The altretamine market is undergoing significant transformation, shaped by emerging oncology trends, complex regulatory environments, and evolving supply chain considerations. For senior decision-makers, gaining precise insights and strategic guidance is essential for optimizing market positioning and capitalizing on new growth avenues.

Altretamine Market Snapshot

The altretamine market expanded from USD 141.33 million in 2024 to USD 147.53 million in 2025 and is forecasted to reach USD 182.48 million by 2030, driven by a CAGR of 4.35%. Altretamine’s longstanding role as an oncology agent continues alongside shifts in therapy protocols, payer expectations, and patient needs. Despite intensified competition and fast-paced drug innovation, its value as a cost-effective oral chemotherapeutic endures, especially in resource-constrained settings and evolving combination regimens.

Scope & Segmentation

This report offers a comprehensive analysis of multiple facets in the altretamine market, focusing on product positioning, distribution, and end-user environments across regions and stakeholders.

  • Distribution Channel: Hospital Pharmacy (Private, Public), Retail Pharmacy (Chain, Independent)
  • End User: Ambulatory Care Centers, Hospitals, Oncology Centers, Specialty Clinics
  • Product Type: Branded, Generic
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina and key US states), Europe, Middle East & Africa (covering major regional markets such as UK, Germany, France, Russia, and GCC nations), Asia-Pacific (including China, India, Japan, Australia, South Korea, and Southeast Asian countries)
  • Company Coverage: Profiles of leading manufacturers, specialized generic producers, and biotech innovators driving market innovation

The report also examines the influence of combination regimens, integration of digital health tools, and evolving procurement behaviors on market dynamics.

Key Takeaways for Senior Decision-Makers

  • Altretamine maintains relevance as an oral therapeutic with a robust safety profile, standing out in regions prioritizing cost-effectiveness and generic access.
  • Growth is supported by its integration into innovative treatment combinations and maintenance therapies, guided by updated clinical practices and regulatory shifts.
  • Diversification in sourcing strategies and local manufacturing partnerships increases supply chain resilience, particularly in response to the shifting tariff landscape.
  • Distribution strategies must be tailored for hospital pharmacy networks versus retail channels, as each shows distinct procurement patterns and patient outreach models.
  • Lifecycle management and real-world data initiatives help prolong branded presence while generic players focus on lowering treatment costs and expanding access regionally.
  • Stakeholders adopting digital adherence platforms and patient assistance programs will likely improve adherence and address commercial and reimbursement challenges.

Tariff Impact on Supply Chain and Pricing

Revised tariff policies in the United States in 2025 are shaping procurement strategies for altretamine. Increased duties on pharmaceutical ingredients prompt manufacturers to diversify supply sources, including partnerships with domestic API providers. This shift can mitigate future cost volatility and align with broader reshoring incentives but necessitates thorough quality assurance and regulatory approvals. The resulting increase in input costs has led to ongoing negotiations with payors and pharmacy benefit managers, with some companies turning to tiered pricing and patient assistance programs to maintain broad access and sustain commercial viability.

Methodology & Data Sources

Findings draw on a rigorous, multi-phase methodology combining secondary research (peer-reviewed studies, regulatory filings, and industry white papers) and structured primary interviews with key market stakeholders, including oncologists, pharmacists, and industry leaders. Data reliability is reinforced through triangulation and peer review, with regional trends validated by local experts.

Why This Report Matters

  • Enables senior executives to anticipate regulatory and commercial shifts that affect supply chains and pricing strategies.
  • Guides optimization of distribution models and partnerships, tailored to evolving demand in specific end-user settings and geographies.
  • Supports data-driven decision-making for investment, lifecycle management, and market expansion initiatives.

Conclusion

This report provides actionable intelligence for executives navigating the complexities of the altretamine market. Strategic focus on supply resilience, innovation, and patient access will enable sustained success in this evolving therapeutic landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Altretamine Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacy
8.2.1. Private Hospital
8.2.2. Public Hospital
8.3. Retail Pharmacy
8.3.1. Chain Pharmacy
8.3.2. Independent Pharmacy
9. Altretamine Market, by End User
9.1. Introduction
9.2. Ambulatory Care Centers
9.3. Hospitals
9.4. Oncology Centers
9.5. Specialty Clinics
10. Altretamine Market, by Product Type
10.1. Introduction
10.2. Branded
10.3. Generic
11. Americas Altretamine Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Altretamine Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Altretamine Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Teva Pharmaceutical Industries Ltd.
14.3.2. Viatris Inc.
14.3.3. Sun Pharmaceutical Industries Ltd.
14.3.4. Aurobindo Pharma Limited
14.3.5. Amneal Pharmaceuticals, Inc.
14.3.6. Apotex Inc.
14.3.7. Camber Pharmaceuticals, Inc.
14.3.8. Sagent Pharmaceuticals, Inc.
14.3.9. Alembic Pharmaceuticals Limited
14.3.10. Bristol-Myers Squibb Company
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. ALTRETAMINE MARKET MULTI-CURRENCY
FIGURE 2. ALTRETAMINE MARKET MULTI-LANGUAGE
FIGURE 3. ALTRETAMINE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ALTRETAMINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ALTRETAMINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ALTRETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ALTRETAMINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ALTRETAMINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ALTRETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ALTRETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ALTRETAMINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ALTRETAMINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ALTRETAMINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ALTRETAMINE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ALTRETAMINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ALTRETAMINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ALTRETAMINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ALTRETAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ALTRETAMINE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ALTRETAMINE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ALTRETAMINE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ALTRETAMINE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ALTRETAMINE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ALTRETAMINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ALTRETAMINE MARKET SIZE, BY ONCOLOGY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ALTRETAMINE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ALTRETAMINE MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ALTRETAMINE MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS ALTRETAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES ALTRETAMINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 35. CANADA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. CANADA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 37. CANADA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 38. CANADA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. CANADA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 40. MEXICO ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. MEXICO ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 42. MEXICO ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 43. MEXICO ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. MEXICO ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. UNITED KINGDOM ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. UNITED KINGDOM ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 63. UNITED KINGDOM ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 64. UNITED KINGDOM ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. UNITED KINGDOM ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. GERMANY ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. GERMANY ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 68. GERMANY ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 69. GERMANY ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. GERMANY ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. FRANCE ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. FRANCE ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 73. FRANCE ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 74. FRANCE ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. FRANCE ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. RUSSIA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. RUSSIA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 78. RUSSIA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. ITALY ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. ITALY ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 83. ITALY ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 84. ITALY ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. ITALY ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. SPAIN ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. SPAIN ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 88. SPAIN ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 89. SPAIN ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. SPAIN ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. UNITED ARAB EMIRATES ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. UNITED ARAB EMIRATES ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 93. UNITED ARAB EMIRATES ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. SAUDI ARABIA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. SAUDI ARABIA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 98. SAUDI ARABIA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 99. SAUDI ARABIA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. SAUDI ARABIA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. SOUTH AFRICA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. SOUTH AFRICA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 103. SOUTH AFRICA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 104. SOUTH AFRICA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. SOUTH AFRICA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. DENMARK ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. DENMARK ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 108. DENMARK ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 109. DENMARK ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. DENMARK ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. NETHERLANDS ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. NETHERLANDS ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 113. NETHERLANDS ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 114. NETHERLANDS ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. NETHERLANDS ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. QATAR ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. QATAR ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 118. QATAR ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 119. QATAR ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. QATAR ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. FINLAND ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. FINLAND ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 123. FINLAND ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 124. FINLAND ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. FINLAND ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. SWEDEN ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. SWEDEN ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. NIGERIA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. NIGERIA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 133. NIGERIA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. EGYPT ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. EGYPT ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 138. EGYPT ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 139. EGYPT ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. EGYPT ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. TURKEY ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. TURKEY ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 143. TURKEY ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 144. TURKEY ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. TURKEY ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. ISRAEL ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. ISRAEL ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 148. ISRAEL ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 149. ISRAEL ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. ISRAEL ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. NORWAY ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. NORWAY ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 153. NORWAY ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 154. NORWAY ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. NORWAY ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. POLAND ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. POLAND ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 158. POLAND ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 159. POLAND ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. POLAND ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. SWITZERLAND ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. SWITZERLAND ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 163. SWITZERLAND ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 164. SWITZERLAND ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. SWITZERLAND ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 172. CHINA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. CHINA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 174. CHINA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 175. CHINA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. CHINA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. INDIA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. INDIA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 179. INDIA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 180. INDIA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. INDIA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. JAPAN ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. JAPAN ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 184. JAPAN ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 185. JAPAN ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. JAPAN ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. AUSTRALIA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. SOUTH KOREA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. SOUTH KOREA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. INDONESIA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. THAILAND ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. THAILAND ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 204. THAILAND ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 205. THAILAND ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. THAILAND ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. PHILIPPINES ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. PHILIPPINES ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 209. PHILIPPINES ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 210. PHILIPPINES ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. MALAYSIA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. MALAYSIA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. SINGAPORE ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. SINGAPORE ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 219. SINGAPORE ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. VIETNAM ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. VIETNAM ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 224. VIETNAM ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. TAIWAN ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. TAIWAN ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN ALTRETAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. ALTRETAMINE MARKET SHARE, BY KEY PLAYER, 2024
TABLE 233. ALTRETAMINE MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Altretamine market report include:
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma Limited
  • Amneal Pharmaceuticals, Inc.
  • Apotex Inc.
  • Camber Pharmaceuticals, Inc.
  • Sagent Pharmaceuticals, Inc.
  • Alembic Pharmaceuticals Limited
  • Bristol-Myers Squibb Company

Table Information

Report AttributeDetails
No. of Pages193
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 147.53 Million
Forecasted Market Value ( USD ) by 2030 $ 182.48 Million
Compound Annual Growth Rate4.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Altretamine (CAS 645-05-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Altretamine (CAS 645-05-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Paclitaxel Market by Formulation, Application, End User, Distribution Channel, Administration Route - Global Forecast to 2030 - Product Image

Paclitaxel Market by Formulation, Application, End User, Distribution Channel, Administration Route - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
Amifostine Market by Application, End User, Indication, Distribution Channel, Route Of Administration, Dose Regimen - Global Forecast to 2030 - Product Image

Amifostine Market by Application, End User, Indication, Distribution Channel, Route Of Administration, Dose Regimen - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Liposomal Doxorubicin Market Size, Share & Trends Analysis Report By Product, By Application (Multiple Myeloma, Ovarian Cancer, Breast Cancer), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Liposomal Doxorubicin Market Size, Share & Trends Analysis Report By Product, By Application (Multiple Myeloma, Ovarian Cancer, Breast Cancer), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Doxorubicin Market Size, Share & Trends Analysis Report By Drug Formulation (Lyophilized Powder, Doxorubicin Injection), By Application, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Doxorubicin Market Size, Share & Trends Analysis Report By Drug Formulation (Lyophilized Powder, Doxorubicin Injection), By Application, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 80 Pages
  • Global
From

About the Altretamine Market

Altretamine is a chemotherapy drug used to treat ovarian cancer. It is classified as an alkylating agent, meaning it works by damaging the DNA of cancer cells, preventing them from growing and dividing. Altretamine is usually used in combination with other chemotherapy drugs, such as cisplatin or carboplatin. It is typically administered intravenously, and is usually given in cycles of three to six weeks. Common side effects of altretamine include nausea, vomiting, hair loss, fatigue, and anemia. Altretamine is a relatively new drug, and is not widely used in the treatment of ovarian cancer. However, it has been shown to be effective in some cases, and is often used in combination with other chemotherapy drugs. It is also used in combination with other treatments, such as radiation therapy and surgery. The altretamine market is a small but growing one, with several companies developing and marketing the drug. These include Teva Pharmaceuticals, Mylan Pharmaceuticals, and Sun Pharmaceuticals. Other companies, such as Pfizer and Merck, are also researching and developing new formulations of altretamine. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.